Straumann Group (STMN) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
Q3 revenue reached CHF 667.1 million, up 10.8% in Swiss francs, with organic growth accelerating to 9.2%; EMEA and APAC led with double-digit growth.
Nine-month revenue totaled CHF 2,046.5 million, up 8.3% organically; currency movements weighed on reported growth.
Full-year 2026 outlook was confirmed, supported by market-share gains, product innovation and disciplined execution.
Financial highlights
Q3 revenue was CHF 667.1 million, up 10.8% in Swiss francs and 9.2% organically.
Nine-month revenue was CHF 2,046.5 million versus CHF 1,890 million a year earlier, up 4.9% in Swiss francs and 8.3% organically.
Currency reduced nine-month revenue by CHF 60 million versus the prior-year base; FX shifted to a Q3 tailwind.
Outlook and guidance
FY2026 outlook confirmed: high-single-digit organic revenue growth and 140–170 bps core EBIT margin improvement at constant 2025 exchange rates, barring unforeseen events.
Midterm targets remain 10% top-line CAGR and 40–50 bps annual improvement in earnings quality; the 2026 profit-guidance increase is not a pull-forward.
ClearCorrect is expected to reach breakeven by end-2027; F.A.S.T. full-arch workflow launch is planned for early 2027 in North America, Europe and Latin America.
Growth plans draw on an innovation pipeline, transformation initiatives and a CHF 20bn+ addressable market.
Latest events from Straumann Group
- Strong H1 2026 growth, margin expansion, and digital innovation drive upgraded outlook.STMN
Q2 2026 - Q1 2026 organic revenue grew 7.1%, with robust regional and segment momentum.STMN
Q1 2026 - 8.9% organic revenue growth, strong margins, and digital-driven innovation in 2025.STMN
Q4 2025 - Targets 10% CAGR revenue and margin expansion by 2030 through digital innovation and operational excellence.STMN
CMD 2025 - Q3 organic revenue rose 8.3%, with strong EMEA/LATAM growth and a confirmed positive outlook.STMN
Q3 2025 - Q3 organic revenue rose 11.2% to CHF 585.5–586M, with 2024 outlook for double-digit growth confirmed.STMN
Q3 2024 - Strong H1 2024 organic growth and digital focus drive upgraded outlook after DrSmile divestiture.STMN
Q2 2024 - Q1 2025 delivered 11% organic growth, led by APAC, EMEA, and digital innovation, with outlook confirmed.STMN
Q1 2025 - 13.7% organic revenue growth to CHF 2.5B, strong global gains, and higher dividend proposed.STMN
Q4 2024